← All stocks

Aprea Therapeutics, Inc.

APRE Net selling
CIK 0001781983 #5292 in the set updated 22 Sep 2026
Bought (120 mo)
$29.84M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$63.91M
$0.00 on a plan · $913.49K straight out of an exercise
Sold at will
$62.99M
21 of 28 sales
Net
−$34.06M
−$33.15M against sales at will

By person

28 insiders · 71 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
5AM Ventures IV, L.P. entity
Former 10% holder
$5.00M (1)
$25.10M (8)
−$20.10M
75,965
$67.61K
ROCKLAGE SCOTT M
Director
$20.01M (6)
−$20.01M
75,965
$67.61K
KDev Investments AB entity
10% owner
$14.93M (2)
−$14.93M
1,992,586
$1.77M
+136.0%
Versant V Luxco S.a r.l.
10% owner
$5.00M (1)
+$5.00M
333,333
$296.67K
Versant Vantage I, L.P.
10% owner
$5.00M (1)
+$5.00M
216,669
$192.84K
Christenson Johan
Director
$4.00M (1)
+$4.00M
2,366,104
$2.11M
+22,308%
HealthCap VII, L.P.
10% owner
$4.00M (1)
+$4.00M
2,366,104
$2.11M
+22,308%
Redmile Group, LLC entity
10% owner
$6.00M (1)
$2.79M (2)
+$3.21M
1,768,718
$1.57M
Korbel Gregory Alan
SVP, Chief Operating Officer
$7.50K (1)
$544.74K (5) scheduled
−$537.24K
45,762
$40.73K
Abrahmsen Lars B.
SVP, Chief Scientific Officer
$368.75K (2) scheduled
−$368.75K
43,700
$38.89K
SCHADE CHRISTIAN S
Director
$189.12K (8)
+$189.12K
265,246
$236.07K
+4,206%
Seizinger Bernd R.
Director
$149.27K (5)
+$149.27K
48,910
$43.53K
Attar Eyal C.
SVP, Chief Medical Officer
$6.00K (2)
$137.01K (2)
−$131.01K
57,564
$51.23K
Duey Marc
Director
$157.19K (3)
$29.58K (1)
+$127.61K
259,892
$231.30K
HENNEMAN JOHN B III
Director
$125.01K (2)
+$125.01K
13,364
$11.89K
Magni Guido
Director
$97.50K (1)
+$97.50K
6,500
$5.79K
Gilad Oren
President/CEO
$55.35K (8)
+$55.35K
393,895
$350.57K
Coiante Scott M
SVP, Chief Financial Officer
$37.50K (1)
+$37.50K
145,065
$129.11K
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
$19.56K (5)
+$19.56K
43,528
$38.74K
Pamukcu Rifat
Director
22,689
$20.19K
Wessels Gregory S.
SVP, Chief Commercial Officer
16,000
$14.24K
Mirza Nadeem Q.
Chief Medical Officer
6,730
$5.99K
Peters Richard
Director
6,254
$5.57K
Grissinger Michael
Director
6,024
$5.36K
Kelly Michael Aaron
Director
4,610
$4.10K
Namouni Fouad
Director
4,610
$4.10K
BIZZARI JEAN-PIERRE
Director
4,180
$3.72K
Gruia Gabriela
Director
4,180
$3.72K

No percentages here. This company's share count has moved by a factor of 2.3 over the window, from 5,434,903 to 12,591,136 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Duey Marc
18 Oct 2024
Director
Sell
6,462
$4.58
$29.58K
Attar Eyal C.
28 Feb 2022
SVP, Chief Medical Officer
Sell
36,000
$1.73
$62.28K
Attar Eyal C.
16 Sep 2021
SVP, Chief Medical Officer
Sell
15,968
$4.68
$74.73K
Redmile Group, LLC
28 Dec 2020
10% owner
Sell indirect
5,863
$5.80
$34.01K
Redmile Group, LLC
28 Dec 2020
10% owner
Sell indirect
494,137
$5.58
$2.76M
5AM Ventures IV, L.P.
5 Oct 2020
Former 10% holder
Sell indirect
175,000
$25.30
$4.43M
KDev Investments AB
7 Jul 2020
10% owner
Sell indirect
241,703
$34.55
$8.35M
5AM Ventures IV, L.P.
16 Jun 2020
10% owner
Sell indirect
19,836
$33.30
$660.54K
5AM Ventures IV, L.P.
16 Jun 2020
10% owner
Sell indirect
4,807
$33.30
$160.07K
5AM Ventures IV, L.P.
16 Jun 2020
10% owner
Sell indirect
115,357
$33.30
$3.84M
ROCKLAGE SCOTT M
16 Jun 2020
Director
Sell indirect
4,807
$33.30
$160.07K
ROCKLAGE SCOTT M
16 Jun 2020
Director
Sell indirect
115,357
$33.30
$3.84M
5AM Ventures IV, L.P.
11 Jun 2020
10% owner
Sell indirect
9,800
$28.75
$281.78K
5AM Ventures IV, L.P.
11 Jun 2020
10% owner
Sell indirect
235,200
$28.75
$6.76M
ROCKLAGE SCOTT M
11 Jun 2020
Director
Sell indirect
9,800
$28.75
$281.78K
ROCKLAGE SCOTT M
11 Jun 2020
Director
Sell indirect
235,200
$28.75
$6.76M
5AM Ventures IV, L.P.
19 May 2020
10% owner
Sell indirect
10,200
$35.15
$358.53K
5AM Ventures IV, L.P.
19 May 2020
10% owner
Sell indirect
244,800
$35.15
$8.60M
ROCKLAGE SCOTT M
19 May 2020
Director
Sell indirect
10,200
$35.15
$358.53K
ROCKLAGE SCOTT M
19 May 2020
Director
Sell indirect
244,800
$35.15
$8.60M
KDev Investments AB
13 Apr 2020
10% owner
Sell indirect
210,548
$31.25
$6.58M

What was left out

Form 4 filings counted 152
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 15
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 7
Sales at will 21
Transactions with no price 0
Shares from compensation/vesting 36,099,927
Sales filed before the plan box existed 20
History held since 7 Oct 2019